Complete pathologic response rate to neoadjuvant chemotherapy increases with increasing HER2 ratio in HER2 over-expressing breast cancer: Analysis of the National cancer database (NCDB)

Category Primary study
JournalCancer Research
Year 2018
This article has no abstract
Epistemonikos ID: 70c00b84fb7d3046e17dc476135eb368482530bb
First added on: Feb 09, 2025